Search

Janice Kerr Phones & Addresses

  • 11312 Penanova St, San Diego, CA 92129
  • Anchorage, AK
  • San Francisco, CA

Professional Records

License Records

Janice Kerr

Phone:
(954) 962-0675
License #:
176917 - Expired
Category:
Health Care
Issued Date:
Nov 10, 2008
Effective Date:
Jan 23, 2012
Expiration Date:
Dec 31, 2009
Type:
Certified Nursing Assistant

Medicine Doctors

Janice Kerr Photo 1

Janice M. Kerr

View page
Specialties:
Endocrinology, Diabetes & Metabolism
Work:
University Physicians Inc Endocrinology
1635 Aurora Ct FL 6, Aurora, CO 80045
(720) 848-2650 (phone), (720) 848-2651 (fax)
Education:
Medical School
University of California, Irvine School of Medicine
Graduated: 1997
Conditions:
Hyperthyroidism
Thyroid Cancer
Abnormal Vaginal Bleeding
Acute Renal Failure
Alopecia Areata
Languages:
English
Spanish
Description:
Dr. Kerr graduated from the University of California, Irvine School of Medicine in 1997. She works in Aurora, CO and specializes in Endocrinology, Diabetes & Metabolism. Dr. Kerr is affiliated with Denver VA Medical Center and University Of Colorado Hospital.

Resumes

Resumes

Janice Kerr Photo 2

Mortgage Broker

View page
Location:
11416 Wills Creek Rd, San Diego, CA 92131
Industry:
Real Estate
Work:
First California Funding
Mortgage Broker
Interests:
Exercise
Home Improvement
Reading
Gourmet Cooking
Sports
Home Decoration
Health
Cooking
Gardening
Electronics
Crafts
Fitness
Music
Movies
Medicine
Automobiles
Travel
Investing
Traveling
Languages:
English
Janice Kerr Photo 3

Loan Consultant

View page
Location:
San Diego, CA
Industry:
Financial Services
Janice Kerr Photo 4

Mortgage Loan Consultant At First California Funding

View page
Location:
San Diego, CA
Industry:
Real Estate
Work:
Kensington Mortgage 1989 - 1992
Owner

First California Funding 1989 - 1992
Mortgage Loan Consultant at First California Funding
Skills:
Mortgage Lending
Refinance
Real Estate Financing
Real Estate
Loans
Credit
Finance
Property
Fha
First Time Home Buyers
Investment Properties
Mortgage Banking
Condos
Residential Mortgages
Public Speaking
Loan Origination
Sales
Short Sales
U.s. Federal Housing Authority
Working With First Time Home Buyers
Janice Kerr Photo 5

Janice Kerr

View page
Janice Kerr Photo 6

Janice Kerr

View page
Janice Kerr Photo 7

Janice Kerr

View page
Janice Kerr Photo 8

Janice Kerr

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Janice Kerr
President
KENSINGTON MORTGAGE
11690 Calamar Dr, San Diego, CA 92124
Janice Kerr
President, Director
Atmsc, Inc
715 J St, San Diego, CA 92101

Publications

Us Patents

Poly (N-Substituted Glycines) With Nucleotide Base Substituents

View page
US Patent:
20020115612, Aug 22, 2002
Filed:
Feb 8, 2002
Appl. No.:
10/071577
Inventors:
Ronald Zuckermann - El Cerrito CA, US
Janice Kerr - Oakland CA, US
Stephen Kent - La Jolla CA, US
Assignee:
Chiron Corporation
International Classification:
A61K038/16
C07K014/00
US Classification:
514/012000, 530/350000
Abstract:
An automated solid-phase method for the synthesis of poly (N-substituted glycines) (referred to herein as poly NSGs) taught here can be used to obtain poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side chain substituents. Each N-substituted glycine monomer is assembled from two “sub-monomers” directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a resin-bound secondary amine with an agent such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the halogen (as a resin-bound -haloacetamide) with an excess of primary amine. The efficient synthesis of a wide variety of oligomeric NSGs using automated synthesis technology, as presented here, makes these polymers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of polymers not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability.

Synthesis Of N-Substituted Oligomers

View page
US Patent:
58310053, Nov 3, 1998
Filed:
May 16, 1995
Appl. No.:
8/441826
Inventors:
Ronald N. Zuckerman - Berkeley CA
Janice M. Kerr - Irvine CA
Stephen B. H. Kent - La Jolla CA
Walter H. Moos - Oakland CA
Reyna J. Simon - Felton CA
Dane A. Goff - Redwood City CA
Assignee:
Chiron Corporation - Emeryville CA
International Classification:
C07K 104
US Classification:
530333
Abstract:
A solid-phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycines) (referred to herein as poly NSGs) is used to obtain oligomers, such as poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two "sub-monomers" directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic is displacement by --NH. sub. 2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound. alpha. -haloacetamide) with a sufficient amount of a second sub-monomer comprising an --NH. sub. 2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like.

Hydrocarbylphenyl Diaminodithiol Radionuclide Complexes And Their Use In Imaging

View page
US Patent:
50808842, Jan 14, 1992
Filed:
Feb 22, 1991
Appl. No.:
7/660403
Inventors:
William J. McBride - Oakland CA
Ronald M. Baldwin - Concord CA
Janice M. Kerr - San Jose CA
Lisa M. Schultze - Oakland CA
Nilda Salazar - Hercules CA
James M. Chinitz - Oakland CA
Assignee:
Medi-Physics, Inc. - Arlington Heights IL
International Classification:
A61K 4902
C07F 1300
US Classification:
424 11
Abstract:
An agent for imaging organs using a radioactive complex of a radioactive metal with a benzene ring having two 2-mercapto-2-methylpropylamino substituents where one of these mercapto substituents is substituted with a hydrocarbyl group.

Hydrocarbylphenyl Diaminodithiol Derivatives

View page
US Patent:
50269135, Jun 25, 1991
Filed:
Aug 30, 1990
Appl. No.:
7/576163
Inventors:
William J. McBride - Oakland CA
Ronald M. Baldwin - Concord CA
Janice M. Kerr - San Jose CA
Lisa M. Schultze - Oakland CA
Nilda Salazar - Hercules CA
Assignee:
Medi-Physics, Inc. - Arlington Heights IL
International Classification:
C07C32100
C07C32300
C07C38100
US Classification:
564440
Abstract:
An agent for imaging organs using a radioactive complex of a radioactive metal with a benzene ring having two 2-mercapto-2-methylpropylamino substitutents where one of these mercapto substituents is substituted with a hydrocarbyl group.

Synthesis Of N-Substituted Oligomers

View page
US Patent:
59773014, Nov 2, 1999
Filed:
Jun 7, 1995
Appl. No.:
8/485106
Inventors:
Ronald N. Zuckerman - Berkeley CA
Janice M. Kerr - Irvine CA
Stephen B. H. Kent - La Jolla CA
Walter H. Moos - Oakland CA
Reyna J. Simon - Telton CA
Dane A. Goff - Redwood City CA
Assignee:
Chiron Corporation - Emeryville CA
International Classification:
C07K 104
US Classification:
530334
Abstract:
A solid-phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycines) (referred to herein as poly NSGs) is used to obtain oligomers, such as poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two "sub-monomers" directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by --NH. sub. 2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound. alpha. -haloacetamide) with a sufficient amount of a second sub-monomer comprising an --NH. sub. 2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like.
Janice S Kerr from San Diego, CA, age ~45 Get Report